BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30875588)

  • 1. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient.
    Ma J; Guo R; Song Y; Zhang J; Feng B; Amponsah AE; Kong D; He J; Zhang W; Liu A; Wei L; Shen S; O'Brien T; Cui H
    Stem Cell Res; 2019 Apr; 36():101417. PubMed ID: 30875588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
    Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
    Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line (ZZUi020-A) from a patient with Parkinson's disease harboring the intermediate-length GGC repeat expansions in the NOTCH2NLC gene.
    Fan Y; Liu F; Fan LY; Mao CY; Liu H; Zhang C; Yuan YP; Yang J; Wang YL; Liu YT; Shi CH; Xu YM
    Stem Cell Res; 2021 Apr; 52():102257. PubMed ID: 33626493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
    Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
    Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation.
    Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
    Stem Cell Res; 2020 May; 45():101781. PubMed ID: 32305865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
    Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease.
    Zheng X; Zhu Z; Chen K; Guo S; Liu T; Liu H
    Stem Cell Res; 2017 Aug; 23():119-121. PubMed ID: 28925360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human induced pluripotent stem cell line (UNAMi001-A) from a Mexican patient with sporadic Parkinson's disease.
    Flores-Ponce X; López-Ornelas A; Escobedo-Avila I; Rodríguez-Violante M; Dávila-Ortiz de Montellano D; Cervantes-Arriaga A; Monroy-Jaramillo N; Velasco I
    Stem Cell Res; 2022 Dec; 65():102972. PubMed ID: 36427474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.
    Lee SY; Jeong S; Kim J; Chung SK
    Stem Cell Res; 2018 Jul; 30():145-149. PubMed ID: 29906669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
    Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
    Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
    Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
    Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene.
    Zanon A; Riekschnitz D; von Troyer M; Volpato C; Picard A; Cantaloni C; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I
    Stem Cell Res; 2019 Dec; 41():101624. PubMed ID: 31715428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
    Lee Y; Jeong D; Ham S; Son J; Ko K
    Stem Cell Res; 2024 Apr; 77():103416. PubMed ID: 38615589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cell (iPSC) line (HEBHMUi002-A) from a healthy female individual and neural differentiation.
    Ma J; Zhang J; He J; Zhang Z; Li W; Feng B; Guo R; Amponsah AE; Kong D; Liu A; Song Y; Wei L; Cui H
    Stem Cell Res; 2020 Jan; 42():101669. PubMed ID: 31791011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.